Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $184
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $199 to $184.
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $199 to $184.